Clorox (NYSE:CLX) PT Lowered to $151.00 at Deutsche Bank Aktiengesellschaft

Clorox (NYSE:CLX) had its price objective trimmed by Deutsche Bank Aktiengesellschaft from $155.00 to $151.00 in a report released on Wednesday morning, Benzinga reports. The firm currently has a hold rating on the stock.

A number of other brokerages also recently commented on CLX. UBS Group raised their target price on shares of Clorox from $145.00 to $170.00 and gave the company a neutral rating in a research note on Friday, February 2nd. DA Davidson restated a neutral rating and set a $162.00 price objective on shares of Clorox in a research note on Monday, February 5th. Barclays lowered their target price on Clorox from $148.00 to $136.00 and set an underweight rating for the company in a research note on Wednesday, April 10th. The Goldman Sachs Group started coverage on Clorox in a report on Friday, March 1st. They set a sell rating and a $140.00 target price on the stock. Finally, JPMorgan Chase & Co. upped their price target on Clorox from $145.00 to $152.00 and gave the stock a neutral rating in a report on Thursday, January 18th. Four equities research analysts have rated the stock with a sell rating and thirteen have assigned a hold rating to the company. According to MarketBeat.com, the company presently has a consensus rating of Hold and a consensus price target of $148.63.

Clorox Price Performance

Shares of Clorox stock opened at $143.58 on Wednesday. The stock has a market capitalization of $17.82 billion, a P/E ratio of 227.90, a PEG ratio of 2.22 and a beta of 0.43. The company has a current ratio of 0.89, a quick ratio of 0.57 and a debt-to-equity ratio of 11.37. The business’s fifty day moving average price is $149.99 and its 200 day moving average price is $141.79. Clorox has a twelve month low of $114.68 and a twelve month high of $178.21.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, February 1st. The company reported $2.16 earnings per share for the quarter, beating the consensus estimate of $1.08 by $1.08. Clorox had a return on equity of 319.41% and a net margin of 1.09%. The business had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.80 billion. During the same period in the previous year, the company posted $0.98 EPS. The company’s revenue was up 16.0% compared to the same quarter last year. As a group, research analysts anticipate that Clorox will post 5.52 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be paid a dividend of $1.20 per share. The ex-dividend date of this dividend is Tuesday, April 23rd. This represents a $4.80 dividend on an annualized basis and a yield of 3.34%. Clorox’s dividend payout ratio (DPR) is 761.90%.

Institutional Investors Weigh In On Clorox

Hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. increased its holdings in Clorox by 0.3% in the third quarter. Vanguard Group Inc. now owns 15,341,234 shares of the company’s stock valued at $2,010,622,000 after buying an additional 44,344 shares during the last quarter. BlackRock Inc. boosted its position in shares of Clorox by 2.1% during the 1st quarter. BlackRock Inc. now owns 9,463,011 shares of the company’s stock valued at $1,497,427,000 after purchasing an additional 195,348 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Clorox by 3.8% during the 1st quarter. Geode Capital Management LLC now owns 2,725,410 shares of the company’s stock valued at $430,349,000 after purchasing an additional 100,920 shares in the last quarter. FMR LLC raised its holdings in shares of Clorox by 17.4% in the 3rd quarter. FMR LLC now owns 2,415,054 shares of the company’s stock worth $316,517,000 after purchasing an additional 357,964 shares in the last quarter. Finally, Stifel Financial Corp lifted its stake in Clorox by 2.2% during the third quarter. Stifel Financial Corp now owns 2,184,875 shares of the company’s stock valued at $286,356,000 after purchasing an additional 47,879 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.